查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1803001

全球组织分离市场：2032 年预测 - 按产品、组织类型、技术、应用、最终用户和地区进行分析

Tissue Dissociation Market Forecasts to 2032 - Global Analysis By Product, Tissue Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球组织解离市场预计在 2025 年达到 3.607 亿美元，到 2032 年将达到 7.301 亿美元，预测期内的复合年增长率为 10.6%。

组织解离是将复杂的生物组织分解成单一可存活细胞的过程，用于治疗方法和治疗应用。该技术对于单细胞分析、细胞培养和流式细胞技术至关重要，使科学家能够精确地研究细胞行为和多样性。处理方法包括机械破碎、酵素消化和化学处理，每种方法都旨在维持细胞的完整性和功能性。将细胞从其原生组织环境中分离出来，使研究人员能够更深入地了解疾病机制、药物反应和再生疗法，使组织解离成为现代生物医学的基本步骤。

根据世界卫生组织（WHO）的数据，预计到2030年，全球慢性病负担将占所有死亡人数的70%。

细胞治疗方法的兴起

由于对高品质单细胞悬浮液的需求不断增长，细胞治疗方法的蓬勃发展正推动组织分离市场的强劲成长。随着再生医学、免疫疗法和干细胞应用的不断扩展，精准高效的分离技术对于下游分析和疗效至关重要。这一势头正在推动酶解和机械分离工具的创新，加速研究工作流程并提高临床可扩展性。最终，这一趋势正在将组织处理转化为下一代生物医学突破的关键推动因素。

酵素的变异性和批次不一致

酵素的变异性和批次不一致严重阻碍了组织分离市场的发展，因为它们会影响可重复性、可扩展性和下游资料的完整性。酵素活性不一致会导致细胞产量和活力难以预测，进而损害研究结果和临床应用的可靠性。这种变异性会增加验证成本，延迟产品开发，并阻碍分离试剂套件在法规环境中的普及。最终，它限制了再生医学、单细胞分析和生物加工领域的市场成长和创新。

单细胞分析的进展

单细胞分析技术的进步正在彻底改变组织分离市场，推动对精准度、扩充性和自动化的需求。微流体和酵素技术的改进使得高产量活细胞分离成为可能，这对于细胞治疗和个人化医疗等下游应用至关重要。与人工智慧和自动化平台的整合可以加速工作流程，减少差异性并提高可重复性。这些技术创新正在推动整个生物製药和研究领域的成长，尤其是在亚太地区，而生物技术领域的支持性政策和投资正在加速市场扩张。

尖端技术成本高昂

先进组织分离技术成本高昂，限制了小型研究机构和新兴生物技术公司的可近性，阻碍了市场成长。这些成本导致营运预算膨胀，限制了其广泛应用，并延缓了细胞治疗方法和诊断领域的创新。此外，成本壁垒阻碍了新兴市场的投资，加剧了全球生物医学研究能力的差距，并降低了组织分离解决方案的整体扩充性和商业性可行性，从而限制了市场扩张。

COVID-19的影响

新冠疫情加速了组织分离市场的需求，这主要得益于疫苗和治疗方法研发的迫切性。儘管初期实验室工作受到干扰，但远端研究和分散式工作流程仍保持了强劲成长动能。组织分离酶和仪器对于单株抗体生产和细胞分析中细胞分离至关重要。生物医学研发的蓬勃发展，尤其是在再生医学和免疫疗法领域，为疫情后市场强劲成长奠定了基础。

再生医学预计将成为预测期内最大的细分市场

受先进酶解和机械解离工具需求的推动，再生医学领域预计将在预测期内占据最大的市场占有率份额。随着细胞疗法、干细胞研究和类器官开发的蓬勃发展，精准的组织处理至关重要。这一趋势正在推动解离试剂和仪器的创新，从而提高细胞产量和活力。随着再生医学扩展到肿瘤学、骨科和神经内科，组织解离技术将成为实现下一代治疗突破的基础，再生医学市场正呈现持续成长动能。

预计动物组织部分将在预测期内实现最高的复合年增长率

动物组织细分市场预计将在预测期内呈现最高成长率，因为它在生产用于研究和治疗应用的高品质单细胞悬浮液方面发挥关键作用。其在酵素解离技术中的应用能够精确降解细胞外基质，进而提高细胞活力和产量。这在肿瘤学、免疫学和再生医学等领域尤其重要。个人化治疗和先进的细胞检测方法的需求日益增长，使得基于动物组织的分离工具变得至关重要，从而刺激了市场扩张和技术创新。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场占有率。受细胞疗法、癌症研究和精准医疗投资不断增加的推动，该地区正见证酶解和机械解离技术的快速应用。这些技术创新实现了高效的单细胞分离，加速了干细胞应用和药物研发的突破。随着医疗基础设施的不断完善和生物技术政策的支持，亚太地区正在成为全球组织解离技术的中心，促进科学进步和治疗创新。

复合年增长率最高的地区：

预计北美在预测期内的复合年增长率最高。对单细胞分析和精准诊断的需求正在推动该地区酶解和机械解离技术的创新。这一势头正在支持肿瘤学、神经科学和干细胞治疗领域的突破，从而提高研究效率和临床疗效。生物技术公司与学术机构之间的策略联盟正在进一步加速技术的应用，使北美成为推动以细胞为基础的应用和个人化医疗解决方案的全球领导者。

免费客製化服务

此报告的订阅者可以从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 市场机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 企业之间的竞争

5. 全球组织分离市场（按产品）

  • 酵素解离产物
  • 机械解离产物
  • 化学解离产物
  • 细胞过滤器
  • 移液管和流量控制装置

6. 全球组织分离市场（依组织类型）

  • 人体组织
  • 固态组织
  • 液体组织
  • 动物组织

7. 全球组织分离市场（依技术）

  • 手动组织解剖
  • 自动组织分离

8. 全球组织分离市场（按应用）

  • 癌症研究
  • 干细胞研究
  • 细胞疗法
  • 再生医学
  • 基因组学和蛋白​​质组学
  • 其他用途

9. 全球组织分离市场（依最终用户）

  • 医院和诊断实验室
  • 学术研究机构
  • 製药和生物技术公司
  • 合约研究业务（CRO）
  • 其他最终用户

第十章。全球组织解离市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购（M&A）
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec
  • Worthington Biochemical Corporation
  • Roche Diagnostics
  • Sigma-Aldrich
  • BD Biosciences
  • STEMCELL Technologies Inc.
  • Corning Incorporated
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • PromoCell GmbH
  • CellSystems Biotechnologie Vertrieb GmbH
  • PanReac AppliChem GmbH
  • Enzymatics Inc.
  • Creative Bioarray
  • Cell Biolabs, Inc.
  • Biovision, Inc.
  • Cyagen Biosciences Inc.
  • Genlantis
  • HiMedia Laboratories Pvt. Ltd.
Product Code: SMRC30527

According to Stratistics MRC, the Global Tissue Dissociation Market is accounted for $360.7 million in 2025 and is expected to reach $730.1 million by 2032 growing at a CAGR of 10.6% during the forecast period. Tissue dissociation is the process of breaking down complex biological tissues into individual, viable cells for research or therapeutic applications. This technique is essential for single-cell analysis, cell culture, and flow cytometry, allowing scientists to study cellular behavior and diversity with precision. Methods include mechanical disruption, enzymatic digestion, and chemical treatments, each tailored to preserve cell integrity and functionality. By isolating cells from their native tissue environment, researchers gain deeper insights into disease mechanisms, drug responses, and regenerative therapies, making tissue dissociation a foundational step in modern biomedical science.

According to the World Health Organization (WHO), the global burden of chronic diseases is projected to reach 70% of all deaths by 2030.

Market Dynamics:

Driver:

Surge in Cell-Based Therapies

The surge in cell-based therapies is catalyzing robust growth in the tissue dissociation market, driven by rising demand for high-quality single-cell suspensions. As regenerative medicine, immunotherapy, and stem cell applications expand, precise and efficient dissociation techniques become critical for downstream analysis and therapeutic efficacy. This momentum is fostering innovation in enzymatic and mechanical dissociation tools, accelerating research workflows and clinical scalability. Ultimately, the trend is transforming tissue processing into a pivotal enabler of next-generation biomedical breakthroughs.

Restraint:

Enzyme Variability and Batch Inconsistency

Enzyme variability and batch inconsistency significantly hinder the tissue dissociation market by compromising reproducibility, scalability, and downstream data integrity. Inconsistent enzymatic activity leads to unpredictable cell yields and viability, undermining confidence in research outcomes and clinical applications. This variability increases validation costs, delays product development, and deters adoption of dissociation kits in regulated environments. Ultimately, it restricts market growth and innovation across regenerative medicine, single-cell analysis, and bioprocessing sectors.

Opportunity:

Advancements in Single-Cell Analysis

Advancements in single-cell analysis are revolutionizing the tissue dissociation market by driving demand for precision, scalability, and automation. Enhanced microfluidic and enzymatic techniques now enable high-yield, viable cell isolation, crucial for downstream applications like cell therapy and personalized medicine. Integration with AI and automated platforms accelerates workflows, reduces variability, and boosts reproducibility. These innovations are catalyzing growth across biopharma and research sectors, especially in Asia-Pacific, where supportive policies and biotech investments are amplifying market expansion.

Threat:

High Costs of Advanced Technologies

The high costs of advanced tissue dissociation technologies significantly hinder market growth by limiting accessibility for smaller research institutions and emerging biotech firms. These expenses inflate operational budgets; restrict widespread adoption, and slow innovation in cell-based therapies and diagnostics. Additionally, cost barriers deter investment in developing regions, exacerbating global disparities in biomedical research capabilities and reducing the overall scalability and commercial viability of tissue dissociation solutions, thus it limits market expansion.

Covid-19 Impact

The Covid-19 pandemic accelerated demand in the tissue dissociation market, driven by urgent vaccine and therapeutic development. Despite initial lab disruptions, remote research and decentralized workflows sustained momentum. Tissue dissociation enzymes and instruments became vital for isolating cells used in monoclonal antibody production and cell-based assays. This surge in biomedical R&D, especially in regenerative medicine and immunotherapy, positioned the market for robust post-pandemic growth.

The regenerative medicine segment is expected to be the largest during the forecast period

The regenerative medicine segment is expected to account for the largest market share during the forecast period, due to demand for advanced enzymatic and mechanical dissociation tools. As cell-based therapies, stem cell research, and organoid development surge, precise tissue processing becomes critical. This trend fosters innovation in dissociation reagents and instruments, enhancing cell yield and viability. With regenerative medicine expanding across oncology, orthopedics, and neurology, the market is witnessing sustained momentum, positioning tissue dissociation as a foundational enabler of next-gen therapeutic breakthroughs.

The animal tissue segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the animal tissue segment is predicted to witness the highest growth rate, due to its critical role in producing high-quality single-cell suspensions for research and therapeutic applications. Its use in enzymatic dissociation techniques enables precise breakdown of extracellular matrices, enhancing cell viability and yield. This is especially vital for fields like oncology, immunology, and regenerative medicine. As demand for personalized therapies and advanced cell-based assays rises, animal tissue-based dissociation tools are becoming indispensable, fueling market expansion and innovation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising investments in cell-based therapies, cancer research, and precision medicine, the region is witnessing rapid adoption of enzymatic and mechanical dissociation technologies. These innovations enable efficient single-cell isolation, accelerating breakthroughs in stem cell applications and drug discovery. With growing healthcare infrastructure and supportive biotech policies, Asia Pacific is emerging as a global hub for tissue dissociation, fostering scientific advancement and therapeutic innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to demand for single-cell analysis and precision diagnostics, the region fosters innovation in enzymatic and mechanical dissociation technologies. This momentum supports breakthroughs in oncology, neuroscience, and stem cell therapies, enhancing research efficiency and clinical outcomes. Strategic collaborations between biotech firms and academic institutions further accelerate adoption, positioning North America as a global leader in advancing cell-based applications and personalized healthcare solutions.

Key players in the market

Some of the key players profiled in the Tissue Dissociation Market include Thermo Fisher Scientific Inc., Miltenyi Biotec, Worthington Biochemical Corporation, Roche Diagnostics, Sigma-Aldrich, BD Biosciences, STEMCELL Technologies Inc., Corning Incorporated, Takara Bio Inc., Bio-Rad Laboratories, Inc., PromoCell GmbH, CellSystems Biotechnologie Vertrieb GmbH, PanReac AppliChem GmbH, Enzymatics Inc., Creative Bioarray, Cell Biolabs, Inc., Biovision, Inc., Cyagen Biosciences Inc., Genlantis and HiMedia Laboratories Pvt. Ltd.

Key Developments:

In July 2025, Thermo Fisher deepens its bond with Sanofi by acquiring a sterile fill-finish site in New Jersey. Over 200 local employees will join the fold, bolstering U.S. drug manufacturing capacity and honoring a tradition of domestic, dependable production. The move strengthens domestic manufacturing and is expected to close in H2 2025.

In July 2025, Takara Bio Europe and MACHEREY-NAGEL have joined forces in a bold distribution pact, delivering MN's precise RNA, DNA, and protein purification tools across ten European nations-melding upstream extraction with downstream PCR and NGS workflows, empowering scientists with seamless reliability.

In March 2025, Roche and Zealand Pharma unite, weaving a promising alliance to co-develop petrelintide-an amylin analog-for standalone use and in fusion with Roche's CT-388. This bold fusion may reshape obesity treatment, confronting its vast complexity and unmet needs with refined innovation.

Products Covered:

  • Enzymatic Dissociation Products
  • Mechanical Dissociation Products
  • Chemical Dissociation Products
  • Cell Strainers
  • Pipettes and Regulated Flow Devices

Tissue Types Covered:

  • Human Tissue
  • Solid Tissue
  • Liquid Tissue
  • Animal Tissue

Technologies Covered:

  • Manual Tissue Dissociation
  • Automated Tissue Dissociation

Applications Covered:

  • Cancer Research
  • Stem Cell Research
  • Cell Therapy
  • Regenerative Medicine
  • Genomics & Proteomics
  • Other Applications

End Users Covered:

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Tissue Dissociation Market, By Product

  • 5.1 Introduction
  • 5.2 Enzymatic Dissociation Products
  • 5.3 Mechanical Dissociation Products
  • 5.4 Chemical Dissociation Products
  • 5.5 Cell Strainers
  • 5.6 Pipettes and Regulated Flow Devices

6 Global Tissue Dissociation Market, By Tissue Type

  • 6.1 Introduction
  • 6.2 Human Tissue
  • 6.3 Solid Tissue
  • 6.4 Liquid Tissue
  • 6.5 Animal Tissue

7 Global Tissue Dissociation Market, By Technology

  • 7.1 Introduction
  • 7.2 Manual Tissue Dissociation
  • 7.3 Automated Tissue Dissociation

8 Global Tissue Dissociation Market, By Application

  • 8.1 Introduction
  • 8.2 Cancer Research
  • 8.3 Stem Cell Research
  • 8.4 Cell Therapy
  • 8.5 Regenerative Medicine
  • 8.6 Genomics & Proteomics
  • 8.7 Other Applications

9 Global Tissue Dissociation Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Diagnostic Laboratories
  • 9.3 Academic & Research Institutes
  • 9.4 Pharmaceutical & Biotechnology Companies
  • 9.5 Contract Research Organizations (CROs)
  • 9.6 Other End Users

10 Global Tissue Dissociation Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fisher Scientific Inc.
  • 12.2 Miltenyi Biotec
  • 12.3 Worthington Biochemical Corporation
  • 12.4 Roche Diagnostics
  • 12.5 Sigma-Aldrich
  • 12.6 BD Biosciences
  • 12.7 STEMCELL Technologies Inc.
  • 12.8 Corning Incorporated
  • 12.9 Takara Bio Inc.
  • 12.10 Bio-Rad Laboratories, Inc.
  • 12.11 PromoCell GmbH
  • 12.12 CellSystems Biotechnologie Vertrieb GmbH
  • 12.13 PanReac AppliChem GmbH
  • 12.14 Enzymatics Inc.
  • 12.15 Creative Bioarray
  • 12.16 Cell Biolabs, Inc.
  • 12.17 Biovision, Inc.
  • 12.18 Cyagen Biosciences Inc.
  • 12.19 Genlantis
  • 12.20 HiMedia Laboratories Pvt. Ltd.

List of Tables

  • Table 1 Global Tissue Dissociation Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Tissue Dissociation Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Tissue Dissociation Market Outlook, By Enzymatic Dissociation Products (2024-2032) ($MN)
  • Table 4 Global Tissue Dissociation Market Outlook, By Mechanical Dissociation Products (2024-2032) ($MN)
  • Table 5 Global Tissue Dissociation Market Outlook, By Chemical Dissociation Products (2024-2032) ($MN)
  • Table 6 Global Tissue Dissociation Market Outlook, By Cell Strainers (2024-2032) ($MN)
  • Table 7 Global Tissue Dissociation Market Outlook, By Pipettes and Regulated Flow Devices (2024-2032) ($MN)
  • Table 8 Global Tissue Dissociation Market Outlook, By Tissue Type (2024-2032) ($MN)
  • Table 9 Global Tissue Dissociation Market Outlook, By Human Tissue (2024-2032) ($MN)
  • Table 10 Global Tissue Dissociation Market Outlook, By Solid Tissue (2024-2032) ($MN)
  • Table 11 Global Tissue Dissociation Market Outlook, By Liquid Tissue (2024-2032) ($MN)
  • Table 12 Global Tissue Dissociation Market Outlook, By Animal Tissue (2024-2032) ($MN)
  • Table 13 Global Tissue Dissociation Market Outlook, By Technology (2024-2032) ($MN)
  • Table 14 Global Tissue Dissociation Market Outlook, By Manual Tissue Dissociation (2024-2032) ($MN)
  • Table 15 Global Tissue Dissociation Market Outlook, By Automated Tissue Dissociation (2024-2032) ($MN)
  • Table 16 Global Tissue Dissociation Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Tissue Dissociation Market Outlook, By Cancer Research (2024-2032) ($MN)
  • Table 18 Global Tissue Dissociation Market Outlook, By Stem Cell Research (2024-2032) ($MN)
  • Table 19 Global Tissue Dissociation Market Outlook, By Cell Therapy (2024-2032) ($MN)
  • Table 20 Global Tissue Dissociation Market Outlook, By Regenerative Medicine (2024-2032) ($MN)
  • Table 21 Global Tissue Dissociation Market Outlook, By Genomics & Proteomics (2024-2032) ($MN)
  • Table 22 Global Tissue Dissociation Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 23 Global Tissue Dissociation Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Tissue Dissociation Market Outlook, By Hospitals & Diagnostic Laboratories (2024-2032) ($MN)
  • Table 25 Global Tissue Dissociation Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 26 Global Tissue Dissociation Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 27 Global Tissue Dissociation Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 28 Global Tissue Dissociation Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.